IGSF11 and cutaneous melanoma: Shekari et al. [19] suggested that although IGSF11 does not serve as a prognostic marker for patients with skin cutaneous melanoma (SKCM), it plays a significant role in promoting the progression of A2058 melanoma cells, indicating its potential as a therapeutic target.